- UNI91103 has been selected as the first agent to be trialed in a study by UK investigators
- If successful, data generated will be used for registration of the product
- The study will include approx.1,500 kidney patients to assess if UNI91103 can prevent patients from contracting symptomatic COVID-19 and / or reduce serious illness and death from the infection
- Kidney patients are considered a high-risk patient population that may not respond well to vaccination
- Niclosamide has been demonstrated to prevent fatal outcomes in an animal model of COVID-19 when administered intranasally
1
HELLERUP, Denmark, Feb. 22, 2021 /PRNewswire/ UNION therapeutics A/S (UNION) has been selected by Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge to trial UNI91103 (intranasal niclosamide) as a prophylactic treatment of COVID-19 in kidney patients, a vulnerable and high-risk patient population.
UNI91103, developed by UNION therapeutics A/S, selected as first agent for prophylactic COVID-19 PROTECT-V study in high-risk patients
prnewswire.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.co.uk Daily Mail and Mail on Sunday newspapers.
Wisbech kidney transplant patient backs tapeworm drug trial
cambstimes.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cambstimes.co.uk Daily Mail and Mail on Sunday newspapers.
Recent deaths and funeral notices announced in the Grimsby Telegraph
Here are some of the loved ones we have lost lately
06:00, 31 JAN 2021
Funeral notices for Albertus Willem Welman, Colin Watkin and Shirley Wylie have been published in the Grimsby Telegraph recently (Image: Funeral Notices)
Sign up to the Grimsby Live newsletter for daily updates and breaking newsInvalid EmailSomething went wrong, please try again later.
Sign up here!
When you subscribe we will use the information you provide to send you these newsletters. Sometimes they’ll include recommendations for other related newsletters or services we offer. OurPrivacy Noticeexplains more about how we use your data, and your rights. You can unsubscribe at any time.